SV2A — Drug Target
All drugs that target SV2A — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- brivaracetam (BRV) tablet · UCB Biopharma SRL · SV2A receptor agonist · Neurology
Brivaracetam is a selective, high-affinity SV2A receptor agonist.